The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Dysfunctional Blood and Target Tissue CD4+CD25high Regulatory T Cells in Psoriasis: Mechanism Underlying Unrestrained Pathogenic Effector T Cell Proliferation
Open accessAbstract
The balance between regulatory and effector functions is important for maintaining efficient immune responses, while avoiding autoimmunity. The inflammatory skin disease psoriasis is sustained by the ongoing activation of pathogenic effector T cells. We found that a CD4+ T lymphocyte subpopulation in peripheral blood, phenotypically CD25high, CTLA-4+, Foxp3high (regulatory T (Treg) cells), is deficient in its suppressor activity in psoriasis. This was associated with accelerated proliferation of CD4+ responder T cells in psoriasis, the majority of which expressed CXCR3. Nevertheless, criss-cross experiments isolated the defect to psoriatic Treg cells. To examine Treg cells in a nonlymphoid tissue of a human T cell-mediated disease, Treg cells were also analyzed and isolated from the site of inflammation, psoriatic lesional skin. At the regulatory vs effector T cells ratios calculated to be present in skin, however, the psoriatic Treg cell population demonstrated decreased suppression of effector T cells. Thus, dysfunctional blood and target tissue CD4+CD25high Treg cell activity may lead to reduced restraint and consequent hyperproliferation of psoriatic pathogenic T cells in vivo. These findings represent a critical component of human organ-specific autoimmune disease and may have important implications with regard to the possible therapeutic manipulation of Treg cells in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
Read, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., & Enk, A. H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1285 · Cited by 1,255
Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific
Thornton, A. M., & Shevach, E. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.183 · Cited by 1,229
Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5317 · Cited by 1,211
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., & Schuler, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1303 · Cited by 1,139
Levings, M. K., Sangregorio, R., & Roncarolo, M.-G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1295 · Cited by 967
Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells
Yamazaki, S., Iyoda, T., Tarbell, K., Olson, K., Velinzon, K., Inaba, K., & Steinman, R. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030422 · Cited by 865
Suri-Payer, E., Amar, A. Z., Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1212 · Cited by 860
Becker, K. G., Simon, R. M., Bailey-Wilson, J. E., Freidlin, B., Biddison, W. E., McFarland, H. F., & Trent, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9979 · Cited by 591
Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo
Walker, L. S. K., Chodos, A., Eggena, M., Dooms, H., & Abbas, A. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030315 · Cited by 588
Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes
Ellis, C. N., & Krueger, G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450403 · Cited by 582
Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells
Fuhlbrigge, R. C., Kieffer, J. D., Armerding, D., & Kupper, T. S. (1997) · Nature · doi:10.1038/40166 · Cited by 577
Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activityin vitro
Stephens, L. A., Mottet, C., Mason, D., & Powrie, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1247::aid-immu1247>3.0.co;2-m · Cited by 486
Dermal injection of immunocytes induces psoriasis.
Wrone-Smith, T., & Nickoloff, B. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118989 · Cited by 439
Nair, R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1349 · Cited by 404
Kriegel, M. A., Lohmann, T., Gabler, C., Blank, N., Kalden, J. R., & Lorenz, H.-M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032158 · Cited by 351
Nestle, F. O., Turka, L. A., & Nickoloff, B. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117308 · Cited by 306
Weinstein, G. D., & Frost, P. (1968) · Journal of Investigative Dermatology · doi:10.1038/jid.1968.37 · Cited by 286
de Jong, R., Bezemer, A. C., Zomerdijk, T. P. L., van de Pouw‐Kraan, T., Ottenhoff, T. H. M., & Nibbering, P. H. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260916 · Cited by 226
Bata-Csorgo, Z., Hammerberg, C., Voorhees, J. J., & Cooper, K. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117659 · Cited by 225
Self-citationFerenczi, K., Burack, L., Pope, M., Krueger, J. G., & Austin, L. M. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0343 · Cited by 164
Prinz, J. C., Groß, B., Vollmer, S., Trommler, P., Strobel, I., Meurer, M., & Plewig, G. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240315 · Cited by 152
Szabo, S. K., Hammerberg, C., Yoshida, Y., Bata‐Csörgõ, Z., & Cooper, K. D. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00419.x · Cited by 148
Self-citationKrueger, J. G., Walters, I. B., Miyazawa, M., Gilleaudeau, P., Hakimi, J., Light, S. E., Sherr, A., & Gottlieb, A. B. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.106515 · Cited by 133
da Silva, A. J., Brickelmaier, M., Majeau, G. R., Li, Z., Su, L., Hsu, Y., & Hochman, P. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4462 · Cited by 132
The mechanisms of action of cyclosporin A in the treatment of psoriasis
Wong, R. L., Winslow, C. M., & Cooper, K. D. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90061-o · Cited by 124
Self-citationBata‐Csörgõ, Z., Cooper, K. D., Ting, K. M., Voorhees, J. J., & Hammerberg, C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci171 · Cited by 84
Self-citationSelective targeting of T cell subsets: focus on alefacept – a remittive therapy for psoriasis
Krueger, G. G. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.4.431 · Cited by 74
Baadsgaard, O., Salvo, B., Mannie, A., DASS, B. A., Fox, D. A., & Cooper, K. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.9.2854 · Cited by 70
Self-citationDavison, S. C., Ballsdon, A. E., Allen, M. H., & Barker, J. N. (2001) · Experimental Dermatology · doi:10.1034/j.1600-0625.2001.100408.x · Cited by 55
Cited by
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789
Metadata
- Authors
- Sugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, S. R., McCormick, T. S., & Cooper, K. D.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-01
- Volume
- 174
- Issue
- 1
- Pages
- 164-173
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1914199395
- Cited by
- 570
- References
- 44
- FWCI
- 13.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.